Actively Recruiting
Impact of a Multidisciplinary Assessment in Day Hospitalization Versus Standard Care on the Deployment of Supportive Oncology Care Recommended by the Personalized Post-cancer Plan in Patients at the End of Initial Treatment for Gynecological Ovarian and Endometrial Cancer Endometrial Cancer
Led by Centre Francois Baclesse · Updated on 2026-01-08
268
Participants Needed
13
Research Sites
208 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This project proposes a structuring of supportive oncology care for the recovery phase after gynecological cancer (ovarian/trope/peritoneum or endometrium). Patients will be divided into three groups based on the identification of oncological support care needs. Patients with supportive oncology care needs will be randomized into two groups: the experimental group, receiving a personalized post-cancer plan with a multidisciplinary assessment of supportive oncology care needs in a day hospital and coordinated follow-up by the referring study nurse, and the control group, receiving a personalized post-cancer plan without a day hospital. Randomization will be stratified according to tumor location (ovary vs. endometrium), use of supportive oncology care during treatment, and treatment center. Patients with no need for supportive oncology care will be followed in an observational cohort. The main objective is to identify and manage the supportive oncology care needs of patients in remission from endometrial or ovarian cancer to improve their quality of life and post-treatment follow-up. A medico-economic analysis will be performed.
CONDITIONS
Official Title
Impact of a Multidisciplinary Assessment in Day Hospitalization Versus Standard Care on the Deployment of Supportive Oncology Care Recommended by the Personalized Post-cancer Plan in Patients at the End of Initial Treatment for Gynecological Ovarian and Endometrial Cancer Endometrial Cancer
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patient over 18 years old
- In remission from first-line treatment of endometrial or ovarian/peritoneal cancer
- Completed initial treatment; maintenance therapy allowed
- Fluent in French
- Access to a telephone line
- Affiliated to a social security scheme
- Signed informed consent before any study procedure
You will not qualify if you...
- Any medical or psychiatric condition preventing study participation
- Locoregional or metastatic cancer recurrence
- Deprived of liberty, under guardianship or curatorship
- Participating simultaneously in a therapeutic clinical trial
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 13 locations
1
CHU, Besançon
Besançon, France
Actively Recruiting
2
François Baclesse
Caen, France
Actively Recruiting
3
Centre Jean Perrin
Clermont-Ferrand, France
Not Yet Recruiting
4
Centre Léon Bérard
Lyon, France
Actively Recruiting
5
Hopital Diaconesses Croix Saint-Simon
Paris, France
Actively Recruiting
6
Hopital Europeen George Pompidou
Paris, France
Not Yet Recruiting
7
Hôpital COCHIN
Paris, France
Not Yet Recruiting
8
Institut Curie
Paris, France
Not Yet Recruiting
9
Hopital privé des Côtes d'Armor
Plérin, France
Not Yet Recruiting
10
Institut Curie, St Cloud
Saint-Cloud, France
Actively Recruiting
11
CHU, Saint Etienne
Saint-Etienne, France
Not Yet Recruiting
12
CHU
Strasbourg, France
Actively Recruiting
13
Gustave Roussy
Villejuif, France
Actively Recruiting
Research Team
F
Florence JOLY, Prof
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
SUPPORTIVE_CARE
Number of Arms
3
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here